NYSE · Healthcare
IQVIA HOLDINGS INC. (IQV)
As-reported financials and recent SEC filings for IQVIA HOLDINGS INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$16.31B
Net income
$1.36B
Net margin
8.3%
Diluted EPS
$7.84
ROE
20.5%
P/E (TTM)
22.5×
Market cap
$30.29B
Debt / equity
2.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $16.31B | $15.40B | $14.98B | $14.41B | $13.87B |
| Gross profit | — | — | — | — | — |
| Operating income | $2.18B | $2.20B | $1.98B | $1.80B | $1.39B |
| Net income | $1.36B | $1.37B | $1.36B | $1.09B | $966.0M |
| Diluted EPS | $7.84 | $7.49 | $7.29 | $5.72 | $4.95 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-04
View on EDGAR →8-K2026-06-03
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →42026-05-11
View on EDGAR →8-K2026-05-07
View on EDGAR →10-Q2026-05-05
View on EDGAR →Go deeper on IQV
Search IQVIA HOLDINGS INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.